The global HAIs control market was valued at USD 50,807.0 million in 2014 and is expected to grow at a CAGR of 8.5% from 2014 to 2020, to reach an estimated value of USD 82,889.4 million in 2020.
HAIs or nosocomial infections refer to infections that are usually contracted during prolonged hospital stays. These infections are caused by the transmission of pathogens from one patient to another or from a healthcare worker to a patient. Causes of HAIs include lack of proper hospital infrastructure, lack of awareness about pathogen transmission among the hospital staff due to lack of training and poor infection control practices in hospitals. In addition, inadequate facilities and insufficient access to techniques for maintaining hygienic conditions in hospitals also lead to HAIs.
For More Information Request TOC (desk of content material), Figures and Tables of the report @ http://www.persistencemarketresearch.com/market-research/hospital-acquired-infection-control-market/toc
Globally, the HAIs control market is witnessing significant growth due to rising aging population and increasing incidence of various HAIs. In addition, hot and humid climatic conditions in some regions and increasing initiatives undertaken by various government associations spreading awareness about prevention and control of HAIs are driving the HAIs control market. However, lack of primary healthcare facilities and infrastructure such as lack of proper buildings, supplies, medical and communication equipment have a restraining impact on the global market for HAIs control. In addition, untrained staff and lack of awareness in some developing regions have a negative impact on the growth of global HAIs market. The global HAIs control market is estimated at USD 50,807.0 million in 2014 and expected to reach USD 82,889.4 million in 2020, growing at a CAGR of 8.5%.
North America has the largest market for the global HAIs control market. This is due to improved healthcare facilities in the region. North American market for HAIs control is estimated at USD 21,319.2 million in 2014 and is expected to reach USD 34,430.3 million in 2020, growing at a CAGR of 8.3%. Asia is the fastest growing region; this is due to increasing prevalence of HAIs cases in the region. In terms of type, cleaning and sterilization is the fastest growing segment. In terms of diseases, market for the treatment of primary bloodstream infections is the fastest growing.
Download Report Sample @ http://www.persistencemarketresearch.com/samples/2814
Some of the latest trends that have been observed in the global HAIs control market include increasing popularity of gas plasma sterilization technology. STERIS Corporation, followed by Getinge AB is a leading player in the global market for HAIs control. Some of the other major players in HAIs control market are Pfizer, Inc., Advanced Sterilization Products Division Ethicon US, LLC, Becton, Dickinson and Company and Hoffmann-La Roche, Ltd.
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Persistence Market Research
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353